ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2973

Exercise Intolerance Evaluated By Invasive Cardiopulmonary Exercise Testing in Connective Tissue Disease: Beyond Pulmonary Hypertension

Rudolf Oliveira1,2, David Systrom2, Julie Tracy2, Abbey Karin2, Aaron Waxman2, Paul Dellaripa3 and Paul Hoover3, 1Medicine, Division of Respiratory Disease, Federal University Of São Paulo, São Paulo, Brazil, 2Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Dyspnea, exercise and mitochondrial myopathy, Pulmonary Involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Exercise
intolerance is common in patients with connective tissue disease (CTD) and may
be related to pulmonary hypertension (PH). However, determining the exact etiology
of the exercise limitation in these patients is challenging due to the
multiorgan involvement of CTDs. The invasive cardiopulmonary exercise testing (iCPET)
combines the non-invasive evaluation of an incremental symptom-limited cycling CPET
with simultaneous pulmonary and radial artery-derived invasive hemodynamics measurements,
and therefore differentiate among cardiovascular, respiratory, metabolic and
peripheral limitations to exercise. In the current study, we evaluated patients
with CTD and exertional intolerance (with or without interstitial lung disease,
ILD) who underwent iCPET. Our aim was to determine the relative contributions
of central cardiac and peripheral mechanisms underlying exertional intolerance
in CTD patients. We hypothesized that CTD without ILD would have multifactorial
reasons for exertional intolerance, beyond PH.

Methods:

683
clinically indicated iCPETs performed at Brigham and Women’s Hospital between
2011-2015 were evaluated. Based on established diagnostic criteria 50 patients had
confirmed CTD (18 SSc, 15 RA, 4 UCTD, 3 SLE, 3 antisynthetase syndrome, 2
CREST, 2 MCTD, 1 psoriatic arthritis, 1 Sjögren’s, 1 Still’s). ILD was defined
by the presence of fibrosis on CT scans of the lungs and a forced vital
capacity < 70% predicted.

Results:

From
the 50 patients evaluated, 15 had CTD-ILD, of which 14 (93%) had PH. Among the
35 patients without ILD, 23 (66%) had a reduced aerobic capacity defined by maximum
oxygen uptake (VO2MAX) < 80% predicted. Out of these 23 patients,
10 (43%) had PH and 13 (57%) had a non-PH related exercise diagnosis, most
commonly a peripheral limitation to exercise (10 of 13). Subgroup analysis of systemic
sclerosis (SSc) patients revealed 10 of 18 (56%) with ILD, and PH was the most
common diagnosis. SSc patients without ILD and a reduced VO2MAX were
more likely to have a peripheral limitation to exercise (5 of 7, Figure 1). VO2MAX
was 62±15% predicted for the CTD-ILD group, 60±16% for CTD without ILD with
PH-related limitation to exercise, and 63±12% for CTD without ILD and a non-PH
disease. There were no significant differences regarding VO2MAX among
these three groups (p>0.05).

Conclusion:

With
direct measures from iCPET, we conclude that while CTD-ILD patients are more
likely to present a PH-related limitation to exercise, CTD patients without ILD
have a higher prevalence of peripheral limitation manifested by impaired
systemic O2 extraction. We speculate the latter may be related to
skeletal muscle mitochondrial dysfunction and/or peripheral microvascular dysfunction.

Figure
1.

 


Disclosure: R. Oliveira, None; D. Systrom, None; J. Tracy, None; A. Karin, None; A. Waxman, None; P. Dellaripa, None; P. Hoover, None.

To cite this abstract in AMA style:

Oliveira R, Systrom D, Tracy J, Karin A, Waxman A, Dellaripa P, Hoover P. Exercise Intolerance Evaluated By Invasive Cardiopulmonary Exercise Testing in Connective Tissue Disease: Beyond Pulmonary Hypertension [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/exercise-intolerance-evaluated-by-invasive-cardiopulmonary-exercise-testing-in-connective-tissue-disease-beyond-pulmonary-hypertension/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exercise-intolerance-evaluated-by-invasive-cardiopulmonary-exercise-testing-in-connective-tissue-disease-beyond-pulmonary-hypertension/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology